Novalac from Bayer not affected by ingredients sourced from New Zealand
Bayer Australia Ltd is aware that on 3 August a regulatory notice was issued regarding a quality and safety issue involving infant formula products made with ingredients produced in New Zealand.
Bayer would like to reassure customers that all ingredients for its range of infant feeding solutions, Novalac, are provided by a European manufacturer in France and are not affected by the issue in New Zealand.
As a duty of care, Bayer requested confirmation from its supplier in Europe that none of its ingredients are sourced from the affected dairy company in New Zealand. This confirmation has now been received.
At Bayer we take the quality and safety of our products very seriously and always closely collaborate with respective regulatory authorities to exchange all relevant information. In addition, Bayer endeavours to keep its customers well informed on situations of concern.
For further information please contact: Fiona Tigar Or Kirsten Impey Tel: 02 9391 6009 Tel: 02 9391 6259 Mob: 0419 705 593 Mob: 0418 695 268
For further information please contact:
Fiona Tigar Or Kirsten Impey
Tel: 02 9391 6009 Tel: 02 9391 6259
Mob: 0419 705 593 Mob: 0418 695 268